NDC 70518-2398

Insulin lispro

Insulin Lispro

Insulin lispro is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Insulin Lispro.

• Product ID: 70518-2398_967cc8c2-a341-2e6d-e053-2a95a90ada6d
• NDC: 70518-2398
• Product Type: Human Prescription Drug
• Proprietary Name: Insulin lispro
• Generic Name: Insulin Lispro
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS; SUBCUTANEOUS
• Marketing Start Date: 2019-10-30
• Marketing Category: NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
• Application Number: NDA020563
• Labeler Name: REMEDYREPACK INC.
• Substance Name: INSULIN LISPRO
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin [Chemical/Ingredient],Insulin Analog [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 70518-2398-0

1 VIAL in 1 CARTON (70518-2398-0) > 10 mL in 1 VIAL

• Marketing Start Date: 2019-10-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70518-2398-0 [70518239800]

Insulin lispro INJECTION, SOLUTION

• Marketing Category: NDA authorized generic
• Application Number: NDA020563
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-10-30

Drug Details

Active Ingredients

Ingredient	Strength
INSULIN LISPRO	100 [iU]/mL

Pharmacological Class

• Insulin [Chemical/Ingredient]
• Insulin Analog [EPC]
• Insulin [Chemical/Ingredient]
• Insulin Analog [EPC]

NDC Crossover Matching brand name "Insulin lispro" or generic name "Insulin Lispro"

NDC	Brand Name	Generic Name
66733-773	Insulin lispro	Insulin lispro
70518-2398	Insulin lispro	Insulin lispro
0002-7737	Insulin Lispro	Insulin Lispro
70518-2802	Insulin Lispro	Insulin Lispro
50090-5391	Insulin Lispro	Insulin Lispro
0002-7510	Humalog	Insulin lispro
0002-7511	Humalog	Insulin lispro
0002-7512	Humalog	Insulin lispro
0002-7516	Humalog	Insulin lispro
0002-7712	Humalog	Insulin lispro
0002-7714	Humalog	Insulin lispro